Skip to main content
2025 ASCRS Annual Scientific Meeting Main banner
Final Program


Visit ASCRS U
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
CME
CME
Invitation/Ticketed Event
Invitation/Ticketed Event
Invited Lectureship
Invited Lectureship
Award Recipient
Award Recipient
Self-Assessment
Self-Assessment
Social
Social
Industry
Industry
Back

Session: ePoster: IBD 1 (Sun8)

EP295 - Herpes Simplex Encephalitis in a Patient Treated with Infliximab for Ulcerative Colitis: A Case Report and Literature Review

Sunday, May 11, 2025
8:27 AM – 8:32 AM PT
Location: Monitor 6, Sails Pavilion, Upper Level

    ePoster Presenter(s)

  • MA

    Maryam Aleissa, MBBS (she/her/hers)

    colorectal surgery fellow
    Henry Ford providence hospital
    Michigan State University College of Human Medicine
    southfild, Michigan, United States

    All of the relevant financial relationships listed below have been mitigated.
    This individual has no financial relationships with ineligible companies.

    • Author(s)

  • RB

    Ryba Bhullar, Medical student

    research assistance
    Henry Ford Providence Hospital
    Southfeild, Michigan, United States

    Disclosure information not submitted.

  • VM

    Vijay k. Mittal, MD

    Hepatobiliary surgeon
    Henry Ford Providence Hospital
    southfild, Michigan, United States

    Disclosure information not submitted.

  • ED

    Ernesto R. Drelichman, MD

    Colorectal surgeon
    Henry Ford providence Hospital
    Southfield, Michigan, United States

    Disclosure information not submitted.

    • Senior Author(s)

  • Jasneet S. Bhullar, MD, MS, FACS, FASCRS.

    Clinical Associate Professor of Surgery MSU/CHM, Program Director Colorectal Surgery Fellowship MSU
    Henry Ford Providence Hospital
    Ascension - MSU Colorectal Surgery Fellowship, MI
    Rochester Hills, Michigan, United States

    All of the relevant financial relationships listed below have been mitigated.
    This individual has no financial relationships with ineligible companies.

All of the relevant financial relationships listed below have been mitigated.
Maryam Aleissa, MBBS: This individual has no financial relationships with ineligible companies.
Jasneet S. Bhullar, MD, MS, FACS, FASCRS.: This individual has no financial relationships with ineligible companies.
Image or Table (Do Not add text here):

Purpose/Background: Infliximab, a TNF-α inhibitor, treats moderate to severe ulcerative colitis (UC) due to its efficacy in inducing clinical remission. While the therapy is generally safe, the risk of viral and bacterial reactivation, including tuberculosis (TB) and hepatitis B (HBV), is a recognized concern. However, reactivation of herpes simplex virus (HSV) and the development of herpes simplex virus encephalitis (HSE) following infliximab therapy is a rare and poorly understood complication.

Methods/Interventions: We report the case of a 54-year-old female with a history of UC, who presented with severe abdominal pain and bloody diarrhea consistent with an exacerbation of her disease. After partial response to corticosteroids, she was transitioned to infliximab therapy. Three days post-infusion, the patient developed acute confusion, aphasia, and respiratory distress, with initial imaging negative for stroke. Further investigation, including cerebrospinal fluid (CSF) analysis and MRI, revealed findings suggestive of central nervous system infection. Lumbar puncture confirmed the diagnosis of HSV-1. The patient was treated with intravenous acyclovir, leading to clinical improvement.

Results/Outcomes: This case highlights the potential for reactivation of latent HSV in patients undergoing TNF-α inhibitor therapy, an association that has been rarely reported. Although TNF-α plays a crucial role in the immune response to HSV infection, the mechanisms by which TNF-α inhibitors trigger viral reactivation remain unclear. Few case reports have been published recently. Along with our case this underscores the importance of clinicians maintaining a high index of suspicion for HSV encephalitis in patients receiving TNF-α inhibitors, even in the absence of typical clinical or radiological findings.

Conclusion/Discussion: Herpes simplex virus encephalitis, while rare, should be considered in patients presenting with neurological symptoms following infliximab therapy. Early recognition and prompt initiation of antiviral therapy are crucial, especially in cases where diagnostic workup is inconclusive but clinical suspicion remains high.